Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease

Inflammatory Bowel Diseases

Volumn 22, Issue 7, 2016, Pages 1533-1539

  Assa, Amit ^a,b,c   Butcher, James ^d   Li, Jennifer ^d   Elkadri, Abdul ^a,b,c   Sherman, Philip M ^a,b,c   Muise, Aleixo M ^a,b,c   Stintzi, Alain ^c   Mack, David ^e  

^a Research Institute   (India)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

children; Faecalibacterium prausnitzii; inflammatory bowel disease; intestinal microbiota

Indexed keywords

C REACTIVE PROTEIN; DNA 16S; BACTERIAL DNA; RIBOSOME DNA;

ADOLESCENT; AMPLICON; ARTICLE; CHILD; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DNA FINGERPRINTING; ERYTHROCYTE SEDIMENTATION RATE; FAECALIBACTERIUM PRAUSNITZII; FEMALE; HUMAN; HUMAN TISSUE; ILEUM MUCOSA; INTESTINE BIOPSY; INTESTINE FLORA; MALE; NONHUMAN; OSCILLOSPIRA; PRIORITY JOURNAL; RUMINOCOCCACEAE; CASE CONTROL STUDY; CLOSTRIDIALES; ILEUM; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CLOSTRIDIALES; CROHN DISEASE; DNA, BACTERIAL; DNA, RIBOSOMAL; FAECALIBACTERIUM PRAUSNITZII; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84976271836     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000776     Document Type: Article

References (48)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54
2. Benchimol EI, Manuel DG, Guttmann A, et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis. 2014;20:1761-1769
3. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317
4. Li J, Butcher J, Mack D, et al. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:139-153
5. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15: 382-392
6. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79
7. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003;52:237-242
8. Mangin I, Bonnet R, Seksik P, et al. Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol. 2004;50:25-36
9. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-211
10. Prindiville T, Cantrell M, Wilson KH. Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. Inflamm Bowel Dis. 2004;10:824-833
11. Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and Diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe. 2015;18:489-500
12. Himmel ME, Yao Y, Orban PC, et al. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology. 2012;136:115-122
13. Manichanh C, Borruel N, Casellas F, et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599-608
14. Kang S, Denman SE, Morrison M, et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis. 2010;16:2034-2042
15. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685-693
16. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006; 55:1760-1767
17. Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139: 1844-1854.e1
18. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421
19. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2009;15:653-660
20. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105:16731-16736
21. Schwiertz A, Jacobi M, Frick JS, et al. Microbiota in pediatric inflammatory bowel disease. J Pediatr. 2010;157:240-244.e1
22. Hansen R, Russell RK, Reiff C, et al. Microbiota of de novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol. 2012;107:1913-1922
23. Jia W, Whitehead RN, Griffiths L, et al. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett. 2010;310:138-144
24. Lopez-Siles M, Martinez-Medina M, Abella C, et al. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease. Appl Environ Microbiol. 2015;81:7582-7592
25. Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795-806
26. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314-1321
27. Hyams J, Markowitz J, Otley A, et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005;41:416-421
28. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc. 2004;60:505-512
29. Pound LD, Patrick C, Eberhard CE, et al. Cathelicidin antimicrobial peptide: a novel regulator of islet function, islet regeneration and selected gut bacteria. Diabetes. 2015;64:4135-4147
30. Magoc T, Salzberg SL. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27:2957-2963
31. Erik Aronesty. ea-utils: Command-line tools for processing biological sequencing data. Available at: http://code.google.com/p/ea-utils. Accessed May 2016
32. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7: 335-336
33. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013; 8:e61217
34. Paulson JN, Stine OC, Bravo HC, et al. Differential abundance analysis for microbial marker-gene surveys. Nat Methods. 2013;10:1200-1202
35. Letunic I, Bork P. Interactive Tree of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res. 2011;39 (Web Server issue):W475-W478
36. Guarner F, Bourdet-Sicard R, Brandtzaeg P, et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006;3:275-284
37. Hausmann M, Kiessling S, Mestermann S, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology. 2002;122:1987-2000
38. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603
39. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594
40. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4
41. Guarner F What is the role of the enteric commensal flora in IBD? Inflamm Bowel Dis. 2008;14(Suppl 2):S83-S84
42. Walker AW, Sanderson JD, Churcher C, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011;11;7
43. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 2009;294:1-8
44. Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis. 2009;22:292-301
45. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63: 1275-1283
46. Dorffel Y, Swidsinski A, Loening-Baucke V, et al. Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapy. Inflamm Bowel Dis. 2012;18:1663-1671
47. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183-1189
48. Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70:5810-5817